These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1. Tranquilizers or anti-depressants for chronic schizophrenics: a long term study. Teja JS; Grey WH; Clums JM; Warren C Aust N Z J Psychiatry; 1975 Dec; 9(4):241-7. PubMed ID: 4053 [TBL] [Abstract][Full Text] [Related]
2. A double-blind trial of amitriptyline/perphenazine, perphenazine and placebo in chronic withdrawn inert schizophrenics. Collins AD; Dundas J Br J Psychiatry; 1967 Dec; 113(505):1425-9. PubMed ID: 4865295 [No Abstract] [Full Text] [Related]
3. A controlled clinical trial of amitriptyline added to perphenazine in the treatment of depressed schizophrenics [proceedings]. Prusoff BA; Williams DH; Weissman MM; Astrachan BM Psychopharmacol Bull; 1979 Apr; 15(2):80-1. PubMed ID: 373008 [No Abstract] [Full Text] [Related]
4. Combined therapy in chronic schizophrenics stabilized on phenothiazine tranquilizers and given BL-KR140 or imipramine or placebo concurrently. Claghorn JL; Schoolar JC; Ryan JW; Kinross-Wright J Curr Ther Res Clin Exp; 1967 Nov; 9(11):576-8. PubMed ID: 4965507 [No Abstract] [Full Text] [Related]
5. Response of postpsychotic depression to adjunctive imipramine or amitriptyline. Siris SG; Rifkin AE; Reardon GT J Clin Psychiatry; 1982 Dec; 43(12):485-6. PubMed ID: 6131064 [TBL] [Abstract][Full Text] [Related]
6. Amisulpride in medium-term treatment of dysthymia: a six-month, double-blind safety study versus amitriptyline. AMILONG investigators. Ravizza L J Psychopharmacol; 1999; 13(3):248-54. PubMed ID: 10512080 [TBL] [Abstract][Full Text] [Related]
7. Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor. Lane HY; Lin CH; Green MF; Hellemann G; Huang CC; Chen PW; Tun R; Chang YC; Tsai GE JAMA Psychiatry; 2013 Dec; 70(12):1267-75. PubMed ID: 24089054 [TBL] [Abstract][Full Text] [Related]
8. Placebo response trajectories in short-term and long-term antipsychotic trials in schizophrenia. Potkin S; Agid O; Siu C; Watsky E; Vanderburg D; Remington G Schizophr Res; 2011 Nov; 132(2-3):108-13. PubMed ID: 21873032 [TBL] [Abstract][Full Text] [Related]
9. The utilization of hypnotics in chronic schizophrenics: some critical remarks. Jus K; Jus A; Villeneuve A; Pires P; Fontaine P Biol Psychiatry; 1979 Dec; 14(6):955-60. PubMed ID: 41605 [TBL] [Abstract][Full Text] [Related]
10. [Drug-induced chronic hallucinosis. A case of chronic hallucinosis in an elderly patient following long-term use of psycholeptic drugs]. von Lieven T; Dietz V; Schulte PW Nervenarzt; 1976 Mar; 47(3):176-8. PubMed ID: 4741 [No Abstract] [Full Text] [Related]
11. The assessment of thiothixene in chronic schizophrenia. A double-blind controlled trial. Burnett GB; Little SR; Graham N; Forrest AD Dis Nerv Syst; 1975 Nov; 36(11):625-9. PubMed ID: 1102277 [TBL] [Abstract][Full Text] [Related]
12. [Effectiveness and tolerance of amitriptyline oxide in chronic tension headache--a multicenter double-blind study versus amitriptyline versus placebo]. Pfaffenrath V; Diener HC; Isler H; Meyer C; Scholz E; Taneri Z; Wessely P; Zaiser-Kaschel H; Haase W; Fischer W Nervenarzt; 1993 Feb; 64(2):114-20. PubMed ID: 8450893 [TBL] [Abstract][Full Text] [Related]
13. Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia. Emsley R; Myburgh C; Oosthuizen P; van Rensburg SJ Am J Psychiatry; 2002 Sep; 159(9):1596-8. PubMed ID: 12202284 [TBL] [Abstract][Full Text] [Related]
14. Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia. Heresco-Levy U; Ermilov M; Shimoni J; Shapira B; Silipo G; Javitt DC Am J Psychiatry; 2002 Mar; 159(3):480-2. PubMed ID: 11870017 [TBL] [Abstract][Full Text] [Related]
15. Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: a 12-week double-blind, placebo-controlled pilot study. Baptista T; Uzcátegui E; Rangel N; El Fakih Y; Galeazzi T; Beaulieu S; de Baptista EA Psychiatry Res; 2008 May; 159(1-2):250-3. PubMed ID: 18374423 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of an amitriptyline-perphenazine combination in chronic schizophrenia. Becker RE Am J Psychiatry; 1970 Dec; 127(6):827-31. PubMed ID: 4921622 [No Abstract] [Full Text] [Related]
17. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group. Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505 [TBL] [Abstract][Full Text] [Related]
18. Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial. Ko YH; Lew YM; Jung SW; Joe SH; Lee CH; Jung HG; Lee MS J Clin Psychopharmacol; 2008 Aug; 28(4):375-83. PubMed ID: 18626263 [TBL] [Abstract][Full Text] [Related]
19. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study. Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179 [TBL] [Abstract][Full Text] [Related]
20. [Double-blind comparison between amitriptyline Diffucaps and ordinary amitriptyline in sleep disorders of depressive origin]. Brasseur R Acta Psychiatr Belg; 1975 Mar; 75(2):182-9. PubMed ID: 788464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]